This is a preview of subscription content, log in via an institution to check access.
Reference
Coleman CI, et al. Cost-Effectiveness of Universal or Phenotype-Driven Selection of Dual Antiplatelet Treatment in Acute Coronary Syndrome. 62nd Annual Scientific Session of the American College of Cardiology : abstr. 901-8, 9 Mar 2013.
Rights and permissions
About this article
Cite this article
Phenotype-driven ticagrelor or prasugrel best way forward. PharmacoEcon Outcomes News 675, 4 (2013). https://doi.org/10.1007/s40274-013-0272-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0272-2